NCT05534620 2025-12-02Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokineticsmedac GmbHPhase 1 Recruiting36 enrolled
NCT00822393 2020-07-30Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)medac GmbHPhase 3 Completed570 enrolled 1 FDA
NCT01063660 2010-02-05Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML)medac GmbHPhase 2 Completed75 enrolled